Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	60.06	24.18	15.11
Graham Fair Price	28.17	100943.91	78760.39
PEG	968.07	0.10	< 0.005
Price/Book	22.13	0.59	0.49
Price/Cash Flow	685.56	-64.74	8.24
Prices/Earnings	-22.58	6.32	8.17
Price/Sales	21.01	2.15	1.78
Price/FCF	685.56	-64.74	8.24
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	13.40	0.23	0.21
Operating Margin	26.69	0.11	0.09
ROA	63.78	0.02	0.01
ROE	0.01	0.02	57.75
ROIC	0.01	0.02	46.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	-0.12	82.39
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	25.28	0.30	-98.79
EPS QOQ	8.41	0.61	-92.75
FCF QOQ	-0.18	-1.16	-542.44
Revenue QOQ	-0.01	0.03	121.24
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	63.02	67.32	6.84
Days Sales Outstanding (DSO)	97.55	98.31	0.77
Inventory Turnover	1.43	1.34	-6.40
Debt/Capitalization	0.19	0.18	-3.30
Quick Ratio	1.39	1.41	1.28
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	136032.71	138813.10	2.04
Cash	24050.19	20467.43	-14.90
Capex	-3198.79	-2576.90	19.44
Free Cash Flow	8032.53	-1274.29	-84.14
Revenue	37254.03	38365.07	2.98
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.85	1.93	4.15
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.04	4.26	109.03
Naive Interpretation	Member

06 - Financial Health · Weak

Rating